Invention Publication
- Patent Title: PHARMACEUTICAL COMPOSITIONS COMPRISING LEVODOPA, A DOPAMINE DECARBOXYLASE INHIBITOR AND A COMTINHIBITOR AND METHOD OF ADMINISTRATION THEREOF
-
Application No.: EP23219005.8Application Date: 2015-09-04
-
Publication No.: EP4356907A1Publication Date: 2024-04-24
- Inventor: BOLSÖY, Roger
- Applicant: LobSor Pharmaceuticals Aktiebolag
- Applicant Address: SE 753 19 Uppsala Kålsängsgränd 10 D
- Assignee: LobSor Pharmaceuticals Aktiebolag
- Current Assignee: LobSor Pharmaceuticals Aktiebolag
- Current Assignee Address: SE 753 19 Uppsala Kålsängsgränd 10 D
- Agency: Brann AB
- Priority: SE 1451034 2014.09.04
- The original application number of the division: 20200070.9 2020.10.05;15838800.9 2015.09.04
- Main IPC: A61K31/198
- IPC: A61K31/198 ; A61K31/277 ; A61K31/165 ; A61K45/06 ; A61K9/06 ; A61K47/38 ; A61P25/16
Abstract:
A pharmaceutical gel composition for intra-intestinal administration comprises (i) a dopamine replacement agents, (ii) a dopamine decarboxylase inhibitor (DDI), and (iii) a COMT inhibitor.
Information query
IPC分类:
